The future of alternative testing in toxicology looks promising. Continued technological advancements, such as the integration of artificial intelligence and machine learning, are expected to enhance the predictive power of in silico models. Moreover, the development of more sophisticated in vitro systems and organ-on-a-chip technologies will likely improve the ability to replicate human biology. Collaborative efforts between scientists, regulatory bodies, and industry stakeholders will be crucial in advancing these methods.
